Biopharmaceutical 3PL Market - Global Industry Analysis

Biopharmaceutical 3PL Market – By Supply Chain (Cold Chain and Non-Cold Chain), By Service Type (Transportation, Warehousing, and Storage), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 17-Jun-2021 Category: Pharmaceutical Report Format : PDF Pages: 150 Report Code: ZMR-6403 Status : Published

The global Biopharmaceutical 3PL market, which was estimated at about 93.1 (USD Billion) in 2019 and is predicted to accrue earnings worth 119.5(USD Billion) by 2026, is set to record a CAGR of nearly over 5.8% during 2020-2026.

Description

The global Biopharmaceutical 3PL market, which was estimated at about  93.1 (USD Billion) in 2019 and is predicted to accrue earnings worth  119.5(USD Billion) by 2026, is set to record a CAGR of nearly over 5.8% during 2020-2026. The report offers valuation and analysis of Biopharmaceutical 3PL market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Biopharmaceutical 3PL Market: Overview

Biopharmaceutical 3PL are the services that are outsourced by pharma firms through third-party vendors. It includes receipt of medicines, biologics, and vaccines in warehouse and fulfilling of inventory orders. Additionally, BioPharma third party logistics helps the pharma & healthcare organizations for maintaining logistics to effectively deliver medicines for patient treatment. It also assists in reducing drug costs through minimization of overhead expenses along with seamless product supply. BioPharma 3PL facilitates enhancement of transport services, thereby raising organizational efficiency.

Precisely, BioPharma 3PL includes activities such as medicine transport by using efficient modes of transport as well as advanced vehicles in which temperature controlling facility is available.

Biopharmaceutical 3PL Market: Growth Dynamics

Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market surge over 2020-2026. In addition to this, increase in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biologics will favorably leverage biopharmaceutical 3PL industry growth in the years ahead. Apart from this, rising ecological awareness among the pharma firms and means adopted by these firms for reducing GHG emissions as a part of corporate social responsibility will prompt the market size.

Furthermore, huge funding of research activities and need for creating value added services will steer the growth of biopharmaceutical 3PL industry over the upcoming years. Discovery of various kinds of precision medicines as well as regenerative drugs will bolster the expansion of biopharmaceutical 3PL industry over the ensuing years. Breakthroughs in biotechnology and introduction of new vaccines as well as novel methods of biomarker testing will create new growth avenues for biopharmaceutical 3PL industry over forecast timeline.

Regional Landscape

North America Biopharmaceutical 3PL Market Size To Hit Scalable Heights By 2026

The growth of regional market during 2020-2026 is due to rise in the imports & exports of biopharmaceutical drugs. Apart from this, humungous healthcare spending along with massive improvement in transport & warehousing as well as logistics activities will steer the size of biopharmaceutical industry in North America over the years ahead.

Competitive Landscape

Key participants profiled in the study are FedEx, DB Schenker, SF Express, DHL International GmbH, United Parcel Service of America, Inc., Kerry Logistics Network Limited, AmerisourceBergen Corporation, and KUEHNE + NAGEL.

The global Biopharmaceutical 3PL Market is segmented as follows:

By Service Type:

  • Warehousing
  • Transportation
  • Storage

By Supply Chain:

  • Cold Chain 
  • Non-Cold Chain

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Biopharmaceutical 3PL Market, 2016–2026 (USD Billion)
    • 2.2. Biopharmaceutical 3PL Market: Snapshot
  • Chapter 3. Global Biopharmaceutical 3PL Market– Industry Analysis
    • 3.1. Biopharmaceutical 3PL Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market size over 2020-2026.
      • 3.2.2. Surge in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biulogics will favorably leverage biopharmaceutical 3PL industry growth in the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Service Type
      • 3.4.2. Market attractiveness analysis By Supply Chain
  • Chapter 4. Global Biopharmaceutical 3PL Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Biopharmaceutical 3PL Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Service launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Biopharmaceutical 3PL Market– Service Type Analysis
    • 5.1. Global Biopharmaceutical 3PL Market overview: By Service Type
      • 5.1.1. Global Biopharmaceutical 3PL Market share, By Service Type , 2019 and 2026
    • 5.2. Warehousing
      • 5.2.1. Global Biopharmaceutical 3PL Market By Warehousing, 2016–2026 (USD Billion)
    • 5.3. Transportation
      • 5.3.1. Global Biopharmaceutical 3PL Market By Transportation, 2016–2026 (USD Billion)
    • 5.4. Storage
      • 5.4.1. Global Biopharmaceutical 3PL Market By Storage, 2016–2026 (USD Billion)
  • Chapter 6. Global Biopharmaceutical 3PL Market– Supply Chain Analysis
    • 6.1. Global Biopharmaceutical 3PL Market overview: By Supply Chain
      • 6.1.1. Global Biopharmaceutical 3PL Market share, By Supply Chain, 2019 and 2026
    • 6.2. Culd Chain
      • 6.2.1. Global Biopharmaceutical 3PL Market By Culd Chain , 2016–2026 (USD Billion)
    • 6.3. Non-Culd Chain
      • 6.3.1. Global Biopharmaceutical 3PL Market By Non-Culd Chain, 2016–2026 (USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. FedEx
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Service Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. DB Schenker
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Service Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. SF Express
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Service Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. DHL International GmbH
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Service Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. United Parcel Service of America, Inc.
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Service Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Kerry Logistics Network Limited
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Service Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. AmerisourceBergen Corporation
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Service Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. KUEHNE + NAGEL.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Service Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Biopharmaceutical  3PL Market attractiveness, By Service Type
6. Global Biopharmaceutical  3PL Market attractiveness, By Supply Chain
7. Global Biopharmaceutical  3PL Market Share by Service Type ,2019 and 2026 (USD Billion)
8. Global Biopharmaceutical  3PL Market by Warehousing, 2016–2026 (USD Billion)
9. Global Biopharmaceutical  3PL Market by Transportation, 2016–2026 (USD Billion)
10. Global Biopharmaceutical  3PL Market by Storage,2016–2026 (USD Billion)
11. Global Biopharmaceutical  3PL Market Share by Supply Chain ,2019 and 2026 (USD Billion)
12. Global Biopharmaceutical  3PL Market by Cold Chain  , and,2016–2026 (USD Billion)
13. Global Biopharmaceutical  3PL Market by Non-Cold Chain,2016–2026 (USD Billion)
14. Global Biopharmaceutical  3PL Market share, by Region, 2019 and 2026
15. North America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
16. Europe Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
17. Asia Pacific Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
18. Latin America Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)
19. The Middle East and Africa Biopharmaceutical  3PL Market, 2016–2026 (USD Billion)


Table Of Tables

List of Tables

1. Global Biopharmaceutical  3PL Market: snapshot
2. Drivers of the Biopharmaceutical  3PL Market: impact analysis
3. North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
4. North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
5. The U.S. Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
6. The U.S. Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
7. Rest of North America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
8.  Rest of North America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
9.  Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
10. Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
11. UK Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
12. UK Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
13. France Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
14. France Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
15. Germany Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
16. Germany Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
17. Rest of Europe Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
18. Rest of Europe Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
19. Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
20. Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
21. China Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
22. China Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
23. Japan  Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
24. Japan Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
25. India Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
26. India Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
27. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
28. Rest of Asia Pacific Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
29. Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
30. Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
31. Brazil Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
32. Brazil Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
33. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
34. Rest of Latin America Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
35. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
36. The Middle East and Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
37. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
38. Saudi Arabia Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
39. South Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
40. South Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)
41. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Service Type, 2016–2026 (USD Billion)
42. Rest of the Middle East & Africa Biopharmaceutical  3PL Market revenue, By Supply Chain, 2016–2026 (USD Billion)


  


 
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Escalating preference for outsourcing logistics and huge focus of giant pharma firms on expanding their distribution networks with huge product sales will steer biopharmaceutical 3PL market surge over 2020-2026. In addition to this, increase in new biosimilar launches will embellish market trends. Moreover, advent of spectrum of biosimilars, generic medicines, and biologics will favorably leverage biopharmaceutical 3PL industry growth in the years ahead. Apart from this, rising ecological awareness among the pharma firms and means adopted by these firms for reducing GHG emissions as a part of corporate social responsibility will prompt the market size.

Furthermore, huge funding of research activities and need for creating value added services will steer the growth of biopharmaceutical 3PL industry over the upcoming years. Discovery of various kinds of precision medicines as well as regenerative drugs will bolster the expansion of biopharmaceutical 3PL industry over the ensuing years.   

According to Zion Market Research report, the global Biopharmaceutical 3PL market, which was estimated at about  93.1 (USD Billion) in 2019 and is predicted to accrue earnings worth  119.5(USD Billion) by 2026, is set to record a CAGR of nearly over 5.8% during 2020-2026.   

North America is likely to make noteworthy contributions towards overall market size over 2020-2026. The growth of the industry in the sub-continent over the estimated timespan is due to rise in the imports & exports of biopharmaceutical drugs. Apart from this, humungous healthcare spending along with massive improvement in transport & warehousing as well as logistics activities will steer the size of biopharmaceutical industry in North America over the years ahead.

The key players profiled in the report include are FedEx, DB Schenker, SF Express, DHL International GmbH, United Parcel Service of America, Inc., Kerry Logistics Network Limited, AmerisourceBergen Corporation, and KUEHNE + NAGEL.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed